Related references
Note: Only part of the references are listed.The effect of selective nigrostriatal dopamine excess on behaviors linked to the cognitive and negative symptoms of schizophrenia
Nicolette A. Moya et al.
NEUROPSYCHOPHARMACOLOGY (2023)
Evidence of trospium's ability to mitigate cholinergic adverse events related to xanomeline: phase 1 study results
Alan Breier et al.
PSYCHOPHARMACOLOGY (2023)
Increased retention of tau PET ligand [18F]-AV1451 in Alzheimer's Disease Psychosis
J. J. Gomar et al.
TRANSLATIONAL PSYCHIATRY (2022)
Anesthesia promotes acute expression of genes related to Alzheimer's disease and latent tau aggregation in transgenic mouse models of tauopathy
John David Eun et al.
MOLECULAR MEDICINE (2022)
Mouse Models of Alzheimer's Disease
Miyabishara Yokoyama et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2022)
Chronic N-Acetylcysteine Treatment Prevents Amphetamine-Induced Hyperactivity in Heterozygous Disc1 Mutant Mice, a Putative Prodromal Schizophrenia Animal Model
Chuan-Ching Lai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Muscarinic acetylcholine receptors for psychotic disorders: bench-side to clinic
Samantha E. Yohn et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2022)
Research Progress in the Study of Startle Reflex to Disease States
Junfeng Zhang et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2022)
Excess tau PET ligand retention in elderly patients with major depressive disorder
Sho Moriguchi et al.
MOLECULAR PSYCHIATRY (2021)
Human wildtype tau expression in cholinergic pedunculopontine tegmental neurons is sufficient to produce PSP-like behavioural deficits and neuropathology
Gabriella King et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2021)
Positive symptom phenotypes appear progressively in EDiPS, a new animal model of the schizophrenia prodrome
Alice Petty et al.
SCIENTIFIC REPORTS (2021)
Effects of Psychostimulants and Antipsychotics on Serum Lipids in an Animal Model for Schizophrenia
Banny Silva Barbosa Correia et al.
BIOMEDICINES (2021)
Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease The ADMET 2 Randomized Clinical Trial
Jacobo Mintzer et al.
JAMA NEUROLOGY (2021)
Substance-Induced Psychoses: An Updated Literature Review
Alessio Fiorentini et al.
FRONTIERS IN PSYCHIATRY (2021)
Tau Seeding Mouse Models with Patient Brain-Derived Aggregates
Aiko Robert et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Prepulse inhibition based grouping of rats and assessing differences in response to pharmacological agents
Sema Oral et al.
NEUROSCIENCE LETTERS (2021)
A Review of the Current Mammalian Models of Alzheimer's Disease and Challenges That Need to Be Overcome
Natasha Elizabeth Mckean et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Animal Models of Psychosis in Alzheimer Disease
Josh M. Krivinko et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2020)
Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs
Sophie J. Bradley et al.
NATURE CHEMICAL BIOLOGY (2020)
Efficacy and Safety of Psychostimulants for Alzheimer's Disease: A Systematic Review and Meta-Analysis
Taro Kishi et al.
PHARMACOPSYCHIATRY (2020)
Prepulse inhibition of the acoustic startle reflex and P50 gating in aging and alzheimer's disease
Zahra Jafari et al.
AGEING RESEARCH REVIEWS (2020)
Dangerous Liaisons: Tau Interaction with Muscarinic Receptors
Adrianna Wysocka et al.
CURRENT ALZHEIMER RESEARCH (2020)
Psychosis in Alzheimer's Disease
Clive Ballard et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2020)
Drug and Disease Effects in Parkinson's Psychosis: Revisiting the Role of Dopamine
Sonali Dave et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2020)
Increased tau phosphorylation follows impeded dopamine clearance in a P301L and novel P301L/COMT-deleted (DM) tau mouse model
Jeremy Koppel et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Progression of Alzheimer's disease, tau propagation, and its modifiable risk factors
Shuko Takeda
NEUROSCIENCE RESEARCH (2019)
PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury
Keisuke Takahata et al.
BRAIN (2019)
Normal and Pathological Tau Uptake Mediated by M1/M3 Muscarinic Receptors Promotes Opposite Neuronal Changes
Viktoriya Morozoya et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy
Lucia Buccarello et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches
Adam L. Boxer et al.
LANCET NEUROLOGY (2017)
Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review
Marco Solmi et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2017)
Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease
Suzanne Reeves et al.
BRAIN (2017)
Sensorimotor gating of the startle reflex: what we said 25 years ago, what has happened since then, and what comes next
Neal R. Swerdlow et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model
Pia Jul et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Phenotypic Characterization of Speed-Associated Gait Changes in Mice Reveals Modular Organization of Locomotor Networks
Carmelo Bellardita et al.
CURRENT BIOLOGY (2015)
Improvement of Learning and Increase in Dopamine Level in the Frontal Cortex by Methylphenidate in Mice Lacking Dopamine Transporter
Y. Takamatsu et al.
CURRENT MOLECULAR MEDICINE (2015)
The muscarinic system, cognition and schizophrenia
Sean P. Carruthers et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
Pathogenic tau species drive a psychosis-like phenotype in a mouse model of Alzheimer's disease
J. Koppel et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Hyperphosphorylated Tau is Elevated in Alzheimer's Disease with Psychosis
Patrick S. Murray et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities
Jeremy Koppel et al.
NEUROBIOLOGY OF AGING (2014)
Memory-related effects of cholinergic receptor ligands in mice as measured by the elevated plus maze test
Kruk Marta et al.
Pharmacological Reports (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Cocaine-Induced Psychotic Disorders: Presentation, Mechanism, and Management
Yilang Tang et al.
JOURNAL OF DUAL DIAGNOSIS (2014)
Optimal treatment of Alzheimer's disease psychosis: challenges and solutions
Jeremy Koppel et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
Elevated CSF Tau is Associated With Psychosis in Alzheimer's Disease
Jeremy Koppel et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models
Christopher M. Acker et al.
NEUROBIOLOGY OF AGING (2013)
Pimavanserin, a 5-HT2A receptor inverse agonist, reverses psychosis-like behaviors in a rodent model of Alzheimer's disease
Diana L. Price et al.
BEHAVIOURAL PHARMACOLOGY (2012)
Methamphetamine-Associated Psychosis
Kathleen M. Grant et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a P301L tau knockin mouse
Jonathan Gilley et al.
NEUROBIOLOGY OF AGING (2012)
Scopolamine Administration Modulates Muscarinic, Nicotinic and NMDA Receptor Systems
Soheil Keihan Falsafi et al.
PLOS ONE (2012)
Reversal of scopolamine-induced disruption of prepulse inhibition by clozapine in mice
Philipp Singer et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
M4 muscarinic receptor knockout mice display abnormal social behavior and decreased prepulse inhibition
Hisatsugu Koshimizu et al.
MOLECULAR BRAIN (2012)
Involvement of decreased muscarinic receptor function in prepulse inhibition deficits in mice reared in social isolation
K. Koda et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons
Sarah Threlfell et al.
FRONTIERS IN SYSTEMS NEUROSCIENCE (2011)
Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice
Mikko Kaenmaki et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Cortical Control of Adaptive Locomotion in Wild-Type Mice and Mutant Mice Lacking the Ephrin-Eph Effector Protein α2-Chimaerin
Curtis Oware Asante et al.
JOURNAL OF NEUROPHYSIOLOGY (2010)
Waxholm Space: An image-based reference for coordinating mouse brain research
G. Allan Johnson et al.
NEUROIMAGE (2010)
Donepezil- and scopolamine-induced rCMRglu changes assessed by PET in conscious rhesus monkeys
Makoto Asai et al.
ANNALS OF NUCLEAR MEDICINE (2009)
Modeling cholinergic aspects of schizophrenia: Focus on the antimuscarinic syndrome
Segev Barak
BEHAVIOURAL BRAIN RESEARCH (2009)
Drugs with anticholinergic properties: a potential risk factor for psychosis onset in Alzheimer's disease?
Iacopo Cancelli et al.
EXPERT OPINION ON DRUG SAFETY (2009)
Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry
S. J. Sawiak et al.
NEUROBIOLOGY OF DISEASE (2009)
Habituation and sensitization of acoustic startle: Opposite influences of dopamine D1 and D2-family receptors
Adam L. Halberstadt et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2009)
Behavioral effects of current Alzheimer's disease treatments: A descriptive review
Jeffrey L. Cummings et al.
ALZHEIMERS & DEMENTIA (2008)
Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia
Anantha Shekhar et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans
Ariel Graff-Guerrero et al.
HUMAN BRAIN MAPPING (2008)
Drugs with anticholinergic properties as a risk factor for psychosis in patients affected by Alzheimer's disease
I. Cancelli et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
D-1 but not D-5 dopamine receptors are critical for LTP, spatial learning, and LTP-Induced arc and zif268 expression in the hippocampus
Noelia Granado et al.
CEREBRAL CORTEX (2008)
A systematic review of the effectiveness of rivastigmine for the treatment of behavioral disturbances in dementia and other neurological disorders
Gary Figiel et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Neural circuits containing pallidotegmental GABAergic neurons are involved in the prepulse inhibition of the startle reflex in mice
Kenji Takahashi et al.
BIOLOGICAL PSYCHIATRY (2007)
Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping
Mark D. Lindner et al.
PSYCHOPHARMACOLOGY (2006)
Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)
M Ramsden et al.
JOURNAL OF NEUROSCIENCE (2005)
Risk of death with atypical antipsychotic drug treatment for dementia - Meta-analysis of randomized placebo-controlled trials
LS Schneider et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Disturbance of sensory filtering in dementia with Lewy bodies: comparison with Parkinson's disease dementia and Alzheimer's disease
MP Perriol et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
A three-dimensional digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy
Y Ma et al.
NEUROSCIENCE (2005)
beta-Amyloid Treatment Sensitizes Mice to Amphetamine-Induced Locomotion but Reduces Response to Caffeine
Oscar P. Dall'Igna et al.
NEURODEGENERATIVE DISEASES (2004)
Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer's disease
ZJ Wynn et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2004)
Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity
D Centonze et al.
JOURNAL OF NEUROSCIENCE (2003)
Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms
C Andorfer et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Congenic D-1A dopamine receptor mutants: Ethologically based resolution of behavioural topography indicates genetic background as a determinant of knockout phenotype
FN McNamara et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies
NR Swerdlow et al.
PSYCHOPHARMACOLOGY (2002)
Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice
R Xu et al.
MOLECULAR PSYCHIATRY (2002)
Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice
DJ Gerber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain
YL Hurd et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2001)
Alterations of striatal dopamine receptor binding in Alzheimer disease are associated with Lewy body pathology and antemortem psychosis
RA Sweet et al.
ARCHIVES OF NEUROLOGY (2001)
Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis
NB Farber et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover:: Positron emission tomography studies with microdialysis in the conscious monkey brain
H Tsukada et al.
JOURNAL OF NEUROSCIENCE (2000)
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
J Lewis et al.
NATURE GENETICS (2000)
Reboxetine: A pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor
EHF Wong et al.
BIOLOGICAL PSYCHIATRY (2000)
Role of dopamine in prepulse inhibition of acoustic startle
JH Zhang et al.
PSYCHOPHARMACOLOGY (2000)
Share Paper
